Twist Bioscience Corporation will hold its annual meeting of stockholders on February 5, 2026. During the meeting, stockholders will vote on the election of three Class II directors to serve for the ensuing three years and until their successors are elected and qualified or until their earlier resignation or removal. Additional proposals to be voted on include a non-binding, advisory vote to approve the compensation of the named executive officers and the ratification of the appointment of the independent registered public accounting firm.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Twist Bioscience Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001581280-26-000006), on January 06, 2026, and is solely responsible for the information contained therein.
Comments